A team of researchers at the University of Cyprus have won a research grant of $100,000 to run a pilot programme for new drugs, to be tested on mice, that could slow the development of Alport Syndrome, a rare kidney condition, it was announced on Friday.
According to a statement, the programme will be run by a team of researchers led by UCy Genetics professor Constantinos Delta.
The programme, the statement added, which was developed by the researchers, will be the first testing of these drugs on animals.
The funding comes from a joint programme of three charity organizations: the US-based Alport Syndrome Foundation (ASF), the Kidney Foundation of Canada (KFOC), and the Pedersen Family.
The programme is expected to commence near the end of 2017 and the main researchers will be Dr Christoforos Odiatis and post-graduate student Pavlos Ioannou.
Odiatis is a lecturer at the UCy’s Biology Department and has extensive experience in testing on mice.